Home › Funds › Bellevue Group AG › EW

Bellevue Group AG position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Bellevue Group AG reported holding 739,234 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$66.9M, representing 1.41% of its reported portfolio and ranking #26 among its reported holdings. Bellevue Group AG has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)739.23K sh
Reported value held$66.87M
Portfolio Weight1.41%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's EW position evolved

Bellevue Group AG first disclosed a stake in EW in Q3 2023 at 1,025,457 shares (US$71.0M). The position peaked in Q2 2024 at 1,260,461 shares, worth US$116.4M. Across 12 filings, Bellevue Group AG increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 739,234 shares valued at US$66.9M — a reduction of -100,217 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.03M $71.04M New
Q4 2023 1.02M $77.70M Reduce
Q1 2024 1.10M $105.42M Add
Q2 2024 1.26M $116.43M Add
Q3 2024 1.13M $74.84M Reduce
Q4 2024 1.10M $81.27M Reduce
Q1 2025 971.97K $70.45M Reduce
Q2 2025 889.08K $69.53M Reduce
Q3 2025 896.63K $69.73M Add
Q4 2025 1.04M $88.92M Add
Q1 2026 839.45K $67.22M Reduce
Q2 2026 739.23K $66.87M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Bellevue Group AG held EW?

Bellevue Group AG has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bellevue Group AG's current position in EW?

As of Q2 2026, Bellevue Group AG holds 739.23K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $66.87M, representing 1.41% of its reported portfolio and ranking #26.

Has Bellevue Group AG been buying or selling EW?

In the latest 13F filing (Q2 2026), Bellevue Group AG reduced its position in EW. The position peaked in Q2 2024 at 1.26M shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.